Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Frydek-Mistek

5 clinical trials in Frydek-Mistek, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Frydek-Mistek at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Frydek-Mistek

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Frydek-Mistek

What the registry says about research in the country

01 Nephrology & Hypertension Studies

Groundbreaking research focusing on chronic kidney disease (CKD) combined with high blood pressure, investigating new combination therapies to slow disease progression and improve patient outcomes.

  • CKD Management
  • Blood Pressure Control
  • Renal Function Preservation

Multiple trials evaluating the effectiveness of innovative drug combinations in protecting kidney function.

02 Cardiovascular Research

Innovative studies targeting atherosclerotic cardiovascular disease and stroke prevention in patients with atrial fibrillation, exploring new therapeutic approaches.

  • Stroke Prevention
  • Heart Attack Prevention
  • Cardiovascular Death Reduction

Trials focusing on reducing major adverse cardiovascular events through novel treatment strategies.

03 Renal Anemia Studies

Clinical research examining treatments for anemia in dialysis patients, comparing different therapeutic options to optimize hemoglobin level control.

  • Hemoglobin Management
  • Dialysis Care
  • Quality of Life Improvement

Comparative studies of various treatments for anemia management in the dialysis population.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.